HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

mtDNA depletion-like syndrome in Wilson disease.

AbstractBACKGROUND AND AIMS:
Wilson disease (WD) is caused by mutations in the copper transporter ATP7B, with its main pathology attributed to copper-mediated oxidative damage. The limited therapeutic effect of copper chelators and the early occurrence of mitochondrial deficits, however, undermine the prevalence of this mechanism.
METHODS:
We characterized mitochondrial DNA copy number and mutations as well as bioenergetic deficits in blood from patients with WD and in livers of tx-j mice, a mouse model of hepatic copper accumulation. In vitro experiments with hepatocytes treated with CuSO4 were conducted to validate in vivo studies.
RESULTS:
Here, for the first time, we characterized the bioenergetic deficits in WD as consistent with a mitochondrial DNA depletion-like syndrome. This is evidenced by enriched DNA synthesis/replication pathways in serum metabolomics and decreased mitochondrial DNA copy number in blood of WD patients as well as decreased mitochondrial DNA copy number, increased citrate synthase activity, and selective Complex IV deficit in livers of the tx-j mouse model of WD. Tx-j mice treated with the copper chelator penicillamine, methyl donor choline or both ameliorated mitochondrial DNA damage but further decreased mitochondrial DNA copy number. Experiments with copper-loaded HepG2 cells validated the concept of a direct copper-mitochondrial DNA interaction.
CONCLUSIONS:
This study underlines the relevance of targeting the copper-mitochondrial DNA pool in the treatment of WD separate from the established copper-induced oxidative stress-mediated damage.
AuthorsValentina Medici, Gaurav V Sarode, Eleonora Napoli, Gyu-Young Song, Noreene M Shibata, Andre O Guimarães, Charles E Mordaunt, Dorothy A Kieffer, Tagreed A Mazi, Anna Czlonkowska, Tomasz Litwin, Janine M LaSalle, Cecilia Giulivi
JournalLiver international : official journal of the International Association for the Study of the Liver (Liver Int) Vol. 40 Issue 11 Pg. 2776-2787 (11 2020) ISSN: 1478-3231 [Electronic] United States
PMID32996699 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Copyright© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Chemical References
  • DNA, Mitochondrial
  • Copper
  • Atp7b protein, mouse
  • Copper-Transporting ATPases
  • Penicillamine
Topics
  • Animals
  • Copper (metabolism)
  • Copper-Transporting ATPases (genetics)
  • DNA, Mitochondrial (genetics)
  • Hepatolenticular Degeneration (drug therapy, genetics)
  • Humans
  • Liver (metabolism)
  • Mice
  • Penicillamine

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: